Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer, Inc.    PFE

PFIZER, INC.

(PFE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
03/30/2020 03/31/2020 04/01/2020 04/02/2020 04/03/2020 Date
32.67(c) 32.64(c) 31.75(c) 32.87(c) 33.64(c) Last
28 409 427 27 959 542 25 341 170 25 794 016 31 138 282 Volume
+5.73% -0.09% -2.73% +3.53% +2.34% Change
More quotes
Financials (USD)
Sales 2020 46 437 M
EBIT 2020 17 735 M
Net income 2020 12 477 M
Debt 2020 31 442 M
Yield 2020 4,54%
Sales 2021 47 081 M
EBIT 2021 18 232 M
Net income 2021 12 579 M
Debt 2021 28 555 M
Yield 2021 4,76%
P/E ratio 2020 16,4x
P/E ratio 2021 15,0x
EV / Sales2020 4,60x
EV / Sales2021 4,48x
Capitalization 182 B
More Financials
Company
Pfizer the world's leading pharmaceutical group. Net sales break down by family of products as follows: - vaccines, oncology products and consumer medicines (62.3%); - generic medicines (37.7%): for treating cardio-vascular diseases, nervous system disorders, infectious and respiratory diseases,... 
Sector
Pharmaceuticals
Calendar
04/23Shareholder meeting
More about the company
Surperformance© ratings of Pfizer, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on PFIZER, INC.
10:57aSIGA TECHNOLOGIES : Says Canadian Department of National Defence Awards Oral TPO..
DJ
05:17aPFIZER : Receives European Approval for Oncology Biosimilar, RUXIENCE
AQ
05:17aPFIZER : Susan Desmond-Hellmann Elected to Pfizer's Board of Directors
AQ
04/02PFIZER : Receives European Approval for Oncology Biosimilar, RUXIENCE™ (ri..
BU
04/02PFIZER : Names Former Gates Foundation CEO Desmond-Hellmann to Board
DJ
04/02PFIZER INC : Change in Directors or Principal Officers, Financial Statements and..
AQ
04/02PFIZER : Susan Desmond-Hellmann Elected to Pfizer's Board of Directors
BU
04/02Pfizer Inc. - Medical Professionals across Merck & Co., Inc., Pfizer Inc., an..
AQ
03/31AILERON THERAPEUTICS : Reports Fourth Quarter and Full Year 2019 Financial Resul..
AQ
03/30PFIZER : GeoMap Clinical Platform Introduces Video Visit Links to Connect Patien..
AQ
03/30PFIZER : Completes $1.25 Billion Sustainability Bond for Social and Environmenta..
AQ
03/27PFIZER INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
03/27PFIZER : Sells $1.25 Billion, 10-Year Sustainability Bond
DJ
03/27Mylan, Lupin Get Positive CHMP Opinion for Enbrel Biosimilar
DJ
03/27PFIZER : Completes $1.25 Billion Sustainability Bond for Social and Environmenta..
BU
More news
News in other languages on PFIZER, INC.
07:27aPFIZER : approbation d'un générique de MabThera en Europe
02:42aCORONAVIRUS : le fil des actus positives
04/01AKTIEN IM FOKUS : Krise schickt Hellofresh sowie Teamviewer & Co auf Rekordhoch
03/26EN DIRECT DES MARCHES : Ipsen, Legrand, ADP, Lagardère, Edenred, Valneva, Eur..
03/26Les valeurs à suivre aujourd'hui à Wall Street Jeudi 26 mars 2020
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 42,38  $
Last Close Price 32,87  $
Spread / Highest target 67,3%
Spread / Average Target 28,9%
Spread / Lowest Target 6,48%
EPS Revisions
Managers
NameTitle
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Mikael Dolsten Chief Scientific Officer
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
W. Don Cornwell Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER, INC.-14.14%181 075
JOHNSON & JOHNSON-8.72%345 705
ROCHE HOLDING AG2.77%277 060
MERCK & CO., INC-16.16%195 141
NOVARTIS-12.10%187 703
NOVO NORDISK A/S5.61%141 503